Wegovy Butt: What Is It and Should You Be Worried?

Why do some people notice changes to their buttocks specifically on semaglutide?

When semaglutide reduces appetite and overall calorie intake, the body draws on stored energy. That energy comes from fat tissue distributed across the whole body, not from one area at a time. The buttocks hold a relatively large proportion of subcutaneous fat for many people, so visible changes there are common as weight falls.

What gives this the colloquial label "semaglutide butt" is partly the speed at which the loss can happen. In the STEP 1 trial published in the New England Journal of Medicine, participants on 2.4mg semaglutide lost an average of around 15% of body weight over 68 weeks. Lose a significant amount of weight in that kind of timeframe and the skin, which adapts more slowly than fat depletes, may appear looser. The buttocks, thighs and abdomen are the areas where this is most commonly remarked upon.

It is also worth knowing that muscle tissue can reduce alongside fat during any calorie deficit, a process called sarcopenia-adjacent lean-mass loss. The gluteal muscles are large and respond well to exercise, but they need a reason to maintain their size. If activity levels drop during treatment (which can happen when appetite falls and energy feels lower during the titration period) muscle follows fat downward.

None of this is unique to semaglutide. The same changes happen with any significant, sustained weight loss. The medicine simply makes achieving that loss more attainable for more people.

Is "Wegovy butt" permanent, or does it improve over time?

For most people, skin does adapt. How much it adapts depends on age, how much weight was lost, how quickly it came off, and individual genetics around skin elasticity. Younger skin tends to recover more fully; skin that has been stretched significantly over many years may not return entirely to its previous texture.

The practical question most people are really asking when they search for this term is whether weight loss through semaglutide is worth a change in appearance. That is genuinely personal. What the research is clear on is that the metabolic, cardiovascular and joint-health benefits of sustained weight loss are substantial. The NHS medicines information for semaglutide sets these in context alongside the known side-effect profile.

Skin changes that occur during the early months of weight loss often look different twelve months later, especially with good hydration, nutrition and consistent resistance training. Some people find that once weight stabilises, the skin has more time to catch up. Others decide the change in shape matters enough to explore further options with their GP. Both responses are valid.

If you are also noticing that the number on the scale is shifting but your measurements are not changing much, our page on losing inches but not weight on Wegovy covers that separately, it is a different pattern with its own explanation.

What can you do to preserve muscle and skin quality during treatment?

This is where there is genuinely useful, actionable information. Resistance exercise (anything that asks your muscles to work against load, from bodyweight squats to gym weights) is the strongest tool available for preserving lean mass during a calorie deficit. Glute-focused movements such as hip thrusts, Romanian deadlifts and walking lunges directly target the muscles most relevant here. Two to three sessions a week is a reasonable starting point; the exact programme is best tailored with a fitness professional.

Protein intake matters too. During calorie restriction, getting enough protein helps the body hold on to muscle rather than breaking it down for energy. General guidance for people losing weight tends to sit around 1.2–1.6 grams of protein per kilogram of body weight per day, though your prescriber or a registered dietitian can give you a figure that fits your situation.

Hydration and micronutrients support skin health. Collagen synthesis depends on vitamin C, among other things. These are not dramatic interventions, they are the kind of straightforward habits that compound over months.

For a broader view of how treatment fits into a wider health plan, the weight-loss treatment overview explains how lifestyle support sits alongside prescription medicine at nume. Understanding how semaglutide works as a GLP-1 receptor agonist also helps make sense of why the body responds the way it does during treatment.

One note from our prescribers: if you are considering starting treatment specifically because of concerns about body composition rather than the health conditions linked to excess weight, that is a useful conversation to have during your consultation. The medicine is licensed for weight management in adults with a qualifying BMI; the prescriber assesses the full picture, not just the number.

If you would like to explore whether semaglutide treatment is clinically appropriate for you, you can start your free consultation with a GPhC-registered prescriber at any time. There is no obligation and no charge for the assessment itself. The cost of treatment, if appropriate, is covered on our Wegovy cost page, and if you want to understand your options before booking, our page on getting started with Wegovy walks through what to expect from the process. If you are ready to move forward, you can also request Wegovy online through our prescribing service, and details on the step 8 semaglutide dose are available if you are already in treatment and approaching the higher maintenance doses. And if you have questions before committing to anything, our team is available through the contact page seven days a week.